Publications dans lesquelles il/elle collabore avec LUISA UGEDO URRUELA (108)

2022

  1. Motor cortico-nigral and cortico-entopeduncular information transmission and its modulation by buspirone in control and after dopaminergic denervation

    Frontiers in Pharmacology, Vol. 13

  2. Preferential Modulatory Action of 5-HT2A Receptors on the Dynamic Regulation of Basal Ganglia Circuits

    Journal of Neuroscience, Vol. 43, Núm. 1, pp. 56-67

2021

  1. Dopaminergic denervation impairs cortical motor and associative/limbic information processing through the basal ganglia and its modulation by the CB1 receptor

    Neurobiology of Disease, Vol. 148

  2. Serotonergic control of the glutamatergic neurons of the subthalamic nucleus

    Progress in Brain Research (Elsevier B.V.), pp. 423-462

  3. The effect of 5-HT1A receptor agonists on the entopeduncular nucleus is modified in 6-hydroxydopamine-lesioned rats

    British Journal of Pharmacology, Vol. 178, Núm. 12, pp. 2516-2532

2020

  1. 6-Hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in the substantia nigra pars reticulata

    British Journal of Pharmacology, Vol. 177, Núm. 17, pp. 3957-3974

  2. Changes in Day/Night Activity in the 6-OHDA-Induced Experimental Model of Parkinson’s Disease: Exploring Prodromal Biomarkers

    Frontiers in Neuroscience, Vol. 14

2019

  1. Acute L-DOPA administration reverses changes in firing pattern and low frequency oscillatory activity in the entopeduncular nucleus from long term L-DOPA treated 6-OHDA-lesioned rats

    Experimental Neurology, Vol. 322

  2. Cannabinoids differentially modulate cortical information transmission through the sensorimotor or medial prefrontal basal ganglia circuits

    British Journal of Pharmacology, Vol. 176, Núm. 8, pp. 1156-1169

  3. Dysfunction of serotonergic neurons in Parkinson's disease and dyskinesia

    International Review of Neurobiology (Academic Press Inc.), pp. 259-279

  4. Effects of adult enriched environment on cognition, hippocampal-prefrontal plasticity and NMDAR subunit expression in MK-801-induced schizophrenia model

    European Neuropsychopharmacology, Vol. 29, Núm. 5, pp. 590-600

  5. Ketamine promotes rapid and transient activation of AMPA receptor-mediated synaptic transmission in the dorsal raphe nucleus

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 88, pp. 243-252

  6. Nanodelivery of therapeutic agents in Parkinson's disease

    Progress in Brain Research (Elsevier B.V.), pp. 263-279

  7. Opioid Activity in the Locus Coeruleus Is Modulated by Chronic Neuropathic Pain

    Molecular Neurobiology, Vol. 56, Núm. 6, pp. 4135-4150

2018

  1. Correction to: Deleterious Effects of VEGFR2 and RET Inhibition in a Preclinical Model of Parkinson’s Disease (Molecular Neurobiology, (2018), 55, 1, (201-212), 10.1007/s12035-017-0733-x)

    Molecular Neurobiology

  2. Deleterious effects of VEGFR2 and RET inhibition in a preclinical model of Parkinson’s disease

    Molecular Neurobiology, Vol. 55, Núm. 1, pp. 201-212

  3. Nanodelivery of cerebrolysin and rearing in enriched environment induce neuroprotective effects in a preclinical rat model of Parkinson’s disease

    Molecular Neurobiology, Vol. 55, Núm. 1, pp. 286-299

  4. The neuroprotective effect of conditioned medium from human adipose-derived mesenchymal stem Cells is impaired by N-acetyl cysteine supplementation

    Molecular Neurobiology, Vol. 55, Núm. 1, pp. 13-25

2017

  1. Activation of Extracellular Signal-Regulated Kinases (ERK 1/2) in the Locus Coeruleus Contributes to Pain-Related Anxiety in Arthritic Male Rats

    International Journal of Neuropsychopharmacology, Vol. 20, Núm. 6, pp. 463-475

  2. Chronic citalopram administration desensitizes prefrontal cortex but not somatodendritic α2-adrenoceptors in rat brain

    Neuropharmacology, Vol. 114, pp. 114